What one share of Omeros holds
Omeros Corporation (“Omeros,” the “Company” or “we”) is an innovative, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders.
Omeros’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | $1.78 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.98 |
| Cash and investments | $0.03 |
| Debt | $1.02 |
| Book value | −$0.71 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $0.20 | −$2.92 | $0.04 | −$2.67 | — | $5.97 |
| 2010 | $0.10 | −$1.37 | $0.04 | −$0.71 | — | $0.93 |
| 2011 | $0.20 | −$1.29 | $0.06 | −$1.21 | — | −$0.25 |
| 2012 | $0.25 | −$1.59 | $0.03 | −$1.46 | — | −$0.25 |
| 2013 | $0.06 | −$1.39 | $0.01 | −$1.05 | — | −$0.61 |
| 2014 | $0.02 | −$2.22 | $0.00 | −$1.75 | — | −$1.25 |
| 2015 | $0.36 | −$2.00 | $0.01 | −$1.74 | — | −$0.69 |
| 2016 | $1.03 | −$1.65 | $0.00 | −$1.28 | — | −$0.85 |
| 2017 | $1.42 | −$1.17 | $0.01 | −$0.80 | — | −$0.06 |
| 2018 | $0.61 | −$2.61 | $0.01 | −$2.15 | — | −$2.04 |
| 2019 | $2.26 | −$1.71 | $0.01 | −$1.22 | — | −$2.01 |
| 2020 | $1.29 | −$2.41 | $0.00 | −$1.76 | — | −$1.96 |
| 2021 | — | $3.12 | $0.00 | −$1.76 | — | $0.38 |
| 2022 | — | $0.76 | $0.00 | −$1.38 | — | $1.36 |
| 2023 | — | −$1.88 | $0.01 | $1.18 | — | −$0.41 |
| 2024 | — | −$2.70 | $0.00 | −$2.56 | — | −$3.15 |
| 2025 | — | −$0.05 | $0.00 | −$1.83 | — | −$1.69 |
Common questions about Omeros
How much does one share of Omeros earn?
Over the last 12 months, each share of Omeros earned $1.78 of profit.
Does Omeros pay a dividend?
Omeros didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Omeros’s book value per share?
Omeros’s book value is negative (−$0.71 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Omeros have?
Each share of Omeros has $0.03 of cash and investments and $1.02 of debt, as of June 30, 2026.
What is Omeros’s free cash flow per share?
−$0.98 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Omeros bought back shares?
Omeros’s share count rose about 779% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.